6-hydroxynicotinic acid

We are 6-hydroxynicotinic acid CAS:5006-66-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:6-hydroxynicotinic acid
CAS.NO:5006-66-6
Synonyms:6-hydroxynicotinic acid
6-oxonicotinic acid
6-Hydroxy Nicotinic Acid
2-hydroxy 5-carboxypyridine
2-Hydroxy-5-pyridine
 
Physical and Chemical Properties:
Density 1.5±0.1 g/cm3
Boiling Point 488.8±30.0 °C at 760 mmHg
Melting Point >300 °C(lit.)
Molecular Formula C6H5NO3
Molecular Weight 139.109
Flash Point 249.4±24.6 °C
 
Specification:
Appearance:White to yellow or beige powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:6-hydroxynicotinic acid is an important chemical intermediate that can produce some important drugs and insecticides. In the latest development of chemical pesticides, pesticides containing nitrogen-containing heterocyclic compounds occupy a major position in pesticides. Pyridine-methylamine pesticides represented by imidacloprid and acetamiprid are highly efficient, broad-spectrum and low-toxic. It has become the focus of new pesticide development today, and 6-hydroxynicotinic acid is an important intermediate for the synthesis of pyridylmethylamine pesticides. At the same time, 6-hydroxynicotinic acid is also widely used in the synthesis of medicines and dyes and materials. For example, it can react with 6-hydroxynicotinic acid and chlorine to form 5,6-dichloronicotinic acid, which is a kind of protein that can prevent the body from absorbing fat. And a substance that promotes the degradation of fat by lipase, can be used as a diet pills. In the field of materials, 6-hydroxynicotinic acid can react with silicon to form a luminescent material.

6-hydroxynicotinic acid


Related News: “CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,” said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.3,5-Dimethyl-4-hydroxybenzonitrile CMO services mainly involve four stages: pre-clinical research, clinical trials, sales of patented drugs after listing, and sales of original drug products after patents expire. Its advantages are: lower cost, guaranteed quality, good capacity flexibility, and favorable process Promotion.1-fluoro-2-(trifluoromethoxy)benzene CAS:2106-18-5 Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical.13578-51-3 The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).

Related Products
Product Name
D-alpha-Cyclohexylglycine View Details
1-(1H-benzimidazol-2-yl)-2,2-dibromoethanone View Details
(2-Methoxynaphthalen-1-yl)boronic acid View Details
(2S)-3-methyl-2-[[(2S)-3-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoyl]amino]butanoic acid manufacturer methyl 4-amino-2-methoxy-5-thiocyanatobenzoate manufacturer Ethyl 3-methylbut-2-enoate manufacturer 1,3-Dibromo-2,2-dimethoxypropane manufacturer N-(9-acetyl-6-oxo-3H-purin-2-yl)acetamide manufacturer